Hodgkin lymphoma (HL) is a malignancy of germinal center (GC) B-cell origin. To explore the role of long noncoding RNAs (lncRNAs) in HL, we studied lncRNA expression patterns in normal B-cell subsets, HL cell lines, and tissues. Naïve and memory B cells showed a highly similar lncRNA expression pattern, distinct from GC-B cells. Significant differential expression between HL and normal GC-B cells was observed for 475 lncRNA loci. For two validated lncRNAs, an enhanced expression was observed in HL, diffuse large B-cell lymphoma, and lymphoblastoid cell lines. For a third lncRNA, increased expression levels were observed in HL and part of Burkitt lymphoma cell lines. RNA fluorescence in situ hybridization on primary HL tissues revealed a tumor cell-specific expression pattern for all three lncRNAs. A potential cis-regulatory role was observed for 107 differentially expressed lncRNA-mRNA pairs localizing within a 60-kb region. Consistent with a cis-acting role, we showed a preferential nuclear localization for two selected candidates. Thus, we showed dynamic lncRNA expression changes during the transit of normal B cells through the GC reaction and widely deregulated lncRNA expression patterns in HL. Three lncRNAs showed a tumor cell-specific expression pattern in HL tissues and might therefore be of value as a biomarker.
Introduction
Hodgkin lymphoma (HL) is a B-cell neoplasm characterized by a minority of neoplastic cells within an extensive inflammatory background. The incidence of HL is about three per 100,000 per year in Western countries and it is most common in adolescents and young adults 1 . HL has been categorized into two disease entities, classical Hodgkin lymphoma (cHL) and nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). cHL accounts for approximately 95% of all cases while NLPHL is less common. The neoplastic cells of cHL, i.e. Hodgkin and Reed-Sternberg (HRS) cells, originate from germinal center (GC) B cells. The HRS cells show a loss of B-cell phenotype with no or strongly reduced expression levels of the B-cell receptor, common B-cell markers and transcription factors 2, 3 . In contrast, the neoplastic cells of NLPHL, i.e. the lymphocyte predominant (LP) cells, have retained their B-cell phenotype 4 . HRS cells can actively influence their microenvironment through the production of various cytokines and a variety of cell surface receptors. Among the factors and pathogens that contribute to cHL pathogenesis are NF-kB and Epstein-Barr virus (EBV) 5 . NF-κB signaling efficiently activates transcription of a variety of genes, which are involved in survival, proliferation and inflammation 6 .
The impact of non-coding (nc)RNAs on hematological malignancies including HL, has been well described for microRNAs (miRNAs) 7 . Next to miRNAs another class of ncRNAs, i.e. the long (l)ncRNAs, have recently received a lot of attention as important regulators of gene expression 8 . LncRNAs are defined as transcripts >200 nucleotides in length that lack protein-coding potential. They are mostly categorized based on their genomic location and orientation compared to protein-coding genes, e.g. sense, antisense, intronic or intergenic 9 . Previously, a subset of lncRNAs has been shown to either positively 10 or negatively 11 regulate neighboring protein-coding genes (cisacting lncRNAs) 12 . For instance, some nuclear lncRNAs were shown to function as transcriptional regulators of protein-coding genes in cis. This mechanism involves three-dimensional folding of chromatin juxtaposing regulatory sequences located several kilobases apart into close spatial proximity (reviewed by 12 ). There is increasing evidence that alterations in the expression levels of lncRNAs are linked to tumorigenesis (reviewed by 13, 14 ) . It is currently unknown to what extent lncRNAs are regulated in B cells during the GC reaction and possibly deregulated in HL.
In this study, we generated lncRNA expression profiles of normal mature B-cell subsets and HL cell lines. RNA fluorescence in situ hybridization (FISH) was used to confirm expression in tumor cells of primary cHL tissues. Finally, we identified putative cisregulatory lncRNAs based on differential expression patterns of nearby protein-coding genes.
Material and Methods

Tissue samples and cell lines
Five FFPE cHL tissue samples were randomly selected from the pathology files of the UMCG tissue bank. All five cHL cases were young adults (20-30 years) , four were of the nodular sclerosis subtype and one was of the mixed cellularity subtype according to WHO classification 15 . EBER in situ hybridization revealed that one of the NS cases was EBV+. Normal B-cell subsets were sorted by FACS from three different tonsil samples as described previously 16 . The procedures were according to the guidelines of the medical ethics board of the University Medical Center Groningen. Written informed consent was obtained for the use of the tonsil samples from the parents of the children. The HL cell lines were cultured at 37°C under an atmosphere containing 5% CO2 in RPMI-1640 medium (Cambrex Biosciences, Walkersville, USA) supplemented with ultraglutamine (2mM), penicillin (100U/ml), streptomycin (0.1mg/ml; Cambrex Biosciences) and 20% (DEV, L540, SUP-HD1), 10% (L1236, KM-H2) or 5% (L428) fetal calf serum (Cambrex Biosciences. We routinely confirmed the identity of our cell lines using the PowerPlex® 16 HS System (Promega, Leiden, The Netherlands).
RNA isolation from cell lines, B-cell subsets and nuclear and cytoplasmic fractions
RNA was isolated from cell lines and B-cell subsets as described earlier 17 . RNA concentration was measured with a NanoDrop TM 1000 Spectrophotometer (Thermo Fisher Scientific Inc., Waltham, USA) and integrity was assessed by analysis of the 18S/28S bands on a 1% agarose gel. Nuclear and cytoplasmic fractions were isolated from the cell lines L1236, L428 and L540 as described previously 17 .
Microarray analysis
Design of the custom lncRNA microarray, labeling and hybridization procedures, data analysis and generation of heatmaps were performed as described previously 17 . Naïve, memory, GC-B and HL cell lines were Cy3 labeled using 50-100ng total RNA. Probes consistently flagged as present and expressed in the th percentile in at least 1 of the 3 conditions for the comparison of naïve, GC-B and memory B cells were included in the statistical analyses. For the comparison of the GC-B and HL samples probes consistently expressed 1 out of 2 conditions were included. We detected 10,469 lncRNA and 17,885 mRNA probes with consistent signals above the background for the 3 B-cell subsets and 9,955 lncRNA and 17,551 mRNA probes for the HL vs GC-B cell comparison. Significant differences in transcript abundance were determined by one-way ANOVA (normal B-cell subsets) or unpaired T-test (HL vs GC-B cells). Benjamini-Hochberg multiple testing correction was applied. Microarray data used for this publication were deposited at NCBI Gene Expression Omnibus under accession GSE81086 (http://www. ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81086).
Quantitative RT-PCR
First strand cDNA was synthesized with 500ng RNA in a total reaction volume of 20µL using the following reagents: random hexamer primers, 10mM dNTP mix, 5× . For analysis of the subcellular localization expression was normalized to 18S when the cytoplasmic fraction was compared to the total fraction and to U3 snoRNA when the nuclear fraction was compared to the total fraction. TABLE S1 contains the sequences of all primers used in this study.
Processing of the cancer genome atlas (TCGA) RNA-Seq data
Fastq files for 20 randomly selected samples per cancer type were mapped to the human genome (build hg19) using tophat. Gene expression values were quantified using Cufflinks software version 2.1.1 (http://cole-trapnell-lab.github.io/cufflinks/releases/ v2.1.1) on the basis of the Ensembl reference transcriptome annotation (version 75).
IHC and RNA-FISH
An immunohistochemical staining for CCL17 was performed as described previously 18 to confirm that the tumor cells were positive for CCL17. FISH probe sets and reagents (QuantiGene ViewRNA ISH Tissue 2-Plex Assay kit) were purchased from Affymetrix (Santa Clara, California, USA). RNA-FISH was performed according to the instructions provided by the manufacturer using formalin-fixed paraffin-embedded tissue sections of 5µm. A probe set for CCL17 was used as a positive control and to identify the HRS tumor cells in combination with one of the three probe sets for the selected lncRNAs. CCL17 was visualized with a TYPE 6 probe set (Fast Blue) and the lncRNAs were visualized with TYPE 1 probe sets (Fast Red). Custom probe sets designed by the manufacturer covered the exons that are common to all isoforms. Slides were imaged on a Leica SP8 confocal microscope.
Identification of differentially expressed lncRNA-mRNA pairs mapping within a 60kb region
To identify putative cis-acting lncRNAs we determined for each differentially expressed lncRNA whether there was a differentially expressed protein-coding gene in close vicinity (directly adjacent) using Galaxy (https://usegalaxy.org) 19, 20 . The genomic coordinates of all differentially expressed probes were uploaded using the get data tool. We next defined the neighboring differentially expressed mRNAs using operate on genomic intervals tools, fetch closest non-overlapping feature for every interval and joint datasets. The resulting dataset was subsequently filtered for lncRNA-mRNA pairs within 60kb of each other.
Results
Highly dynamic lncRNA expression changes during the germinal center reaction
Statistical analysis of the gene expression profiles generated for naïve, GC and memory B-cells revealed 401 significantly differentially expressed lncRNA probes (251 lncRNA loci) (ANOVA, FDR<0.05) with a fold change of at least 2 in expression levels. The naïve and memory B-cell subsets showed a highly similar expression pattern with a significantly differential expression for only 2 probes. In contrast, GC-B cells showed a distinct lncRNA expression pattern with 377 differentially expressed probes compared to naïve and 376 compared to memory B cells. Unsupervised hierarchical clustering using the 401 lncRNA probes revealed two distinct clusters, one cluster with the GC-B cell samples and a second cluster with the naïve and memory B-cell subsets (FIGURE 1A). Analysis of the differentially expressed mRNAs (2,908 probes, 2,505 loci) revealed a clustering pattern similar to that of lncRNAs (FIG. S1A) .
Next, we clustered the 6 HL cell lines together with the B-cell subsets using the 401 lncRNA probes that were significantly different between the three normal B-cell subsets. This revealed a pair-wise clustering of the GC-B cells and HL cell lines in one tree and the naïve and memory B-cells in a separate tree (FIGURE 1B). The nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) cell line DEV clustered in the same branch as the GC-B cells, while the 5 cHL cell lines clustered in a separate branch next to the GC-B cells. This is in line with the GC-B cell origin of the tumor cells of HL, with a loss-of-B-cell phenotype in cHL but not in NLPHL. A similar result was observed using the 2,908 mRNA probes that were differentially expressed between the normal B-cell subsets (FIG. S1B) .
LncRNA expression is widely deregulated in cHL
Comparison of the expression profiles of cHL (excluding the NLPHL cell line DEV) to GC-B cells revealed a significantly differential expression for 639 lncRNA probes (475 lncRNA loci) (FIGURE 1C). Comparison of the mRNA expression profiles revealed 2,402 LncRNAs were predominantly downregulated in HL (74% down vs 26% up), whereas mRNAs showed a more equal distribution between up and downregulated transcripts (56% down vs 44% up).
Comparison of the lncRNAs and mRNAs differentially expressed between the normal B-cell subsets and between cHL cell lines and GC-B cells revealed a limited overlap of 70 lncRNA and 581 mRNA probes.
To validate the differential expression patterns we designed qRT-PCR primer sets for 9 up-and 5 downregulated lncRNAs randomly selected from the set of lncRNAs differentially expressed between cHL and GC-B cells. All 9 upregulated lncRNAs A B C
showed a higher expression in cHL consistent with the microarray data, with significant differences for 6 of them (FIG. S2) . For the downregulated lncRNAs we could confirm significant changes for 3 out of 5 lncRNAs. For the remaining 2 lncRNAs we were not able to design primer sets that could amplify these lncRNA transcripts. Reanalysis of TCGA RNA-seq data across 24 different cancer types revealed relative low expression levels for FLJ42351 and LINC00116 without clear differences between different cancer tissues (right panels of FIGURE 2). For LINC00461, higher levels were observed only for lower grade glioma.
Next, we used RNA-FISH to study the expression of the three in cHL cell lines upregulated lncRNAs in tissue sections of primary cHL cases. The five randomly selected cHL cases showed positive staining for CCL17 by immunohistochemistry (data not shown). RNA-FISH using the CCL17 probe-set as a positive control revealed staining of the HRS cells in four of the five cases. RNA-FISH using the lncRNA probe-sets revealed a tumor cell specific staining in the four remaining cHL cases for all three lncRNAs (FIGURE 3). The probe-sets for FLJ42351 and LINC00461 showed positive signals in three cases and weak positive signals in one case, the probe set for LINC00116 showed positive signals in all four cases. (Table S2 ).
LncRNAs and neighboring protein-coding genes
To identify lncRNAs that potentially affect the expression of nearby protein-coding genes we determined which of the differentially expressed lncRNAs was close to a differentially expressed mRNA. Within the 251 lncRNAs differentially expressed between the normal B-cell subsets we identified 51 putative cis-regulatory lncRNAs with a probe-to-probe distance of up to 60kb to the differentially expressed mRNA (TABLE S2) . Of the 475 lncRNAs differentially expressed between cHL and GC-B cells 59 were in close vicinity of a differentially expressed mRNA (TABLE 1) .
Three of the putative cis-regulated lncRNA-mRNA pairs were detected in both the normal B-cell subsets and the HL versus GC-B cell analysis (indicated in bold). For all three pairs a positive correlation between the lncRNA and mRNA expression was observed in both analyses.
To support a putative cis-regulatory role we determined for two (LINC00461 and FLJ42351) of the lncRNAs for which we already designed qPCR primers whether they were preferentially localized in the nucleus. Fractionation procedures of L428, L1236 and L540 cell lines were validated by qPCR for six transcripts with a known subcellular localization. This revealed the expected enrichment of RPPH1, DANCR and MT-TK transcripts in the cytoplasmic fractions and of MIAT1, ANRIL and XIST transcripts in the nuclear fractions (FIGURE 4A AND 4B ). In line with a cis-regulatory role, LINC00461 and FLJ42351 indeed showed enrichment in the nuclear fractions and depletion in the cytoplasmic fractions. Analysis of the putative cis-regulated protein-coding genes by qRT-PCR confirmed the inverse expression pattern between LINC00461 and the nearby upstream protein-coding gene, MEF2C (FIGURE S2C). For FLJ42351, we could confirm the comparable expression patterns for this lncRNA and the neighboring protein-coding gene SLC20A1. A B
Discussion
In this study, we showed a dynamic regulation of lncRNA expression during the transition of B cells through the GC, i.e. from naïve B cell to GC-B cell resulting in memory B cells. Furthermore, the comparison of cHL cell lines with GC-B cells revealed a significant differential expression pattern for a considerable number of lncRNAs. This indicates that lncRNAs play a role in normal B-cell maturation and that deregulated lncRNA expression is a prominent feature of HL.
We showed that the levels of 401 probes corresponding to 251 lncRNA loci change during the transition from naïve to GC-B cells and reverse to levels comparable to naïve B cells once the cells differentiate to memory B cells. Recently, four studies analyzed lncRNA expression in B-cell populations [21] [22] [23] [24] . Only one of the four studies also analyzed naïve, memory and germinal center B-cell populations isolated from tonsil. In line with our study, they showed that the lncRNA expression profiles of memory and naïve B cells were similar and more distinct from GC-B cells 21 . However, none of the studies provided overviews of the lncRNAs differentially expressed between similar B-cell subsets as used in our study preventing a direct comparison to our results. At the mRNA level we and others observed a similar pattern as we observed for lncRNAs, i.e. similar profiles for naïve and memory B cells and significantly different profiles for GC-B cells A direct comparison of cHL cell lines with GC-B cells revealed significant differences for 639 probes (475 lncRNA loci). Almost 75% of these lncRNAs were downregulated in the cHL cell lines, while the percentage of up and downregulated mRNAs was quite similar. This suggests that lncRNAs might, similar to microRNAs, 28 show a global downregulation in cancer. Previous studies comparing the expression profiles of microdissected primary HRS cells and cHL cell lines to GC-B cells showed a considerable overlap between the differentially expressed genes in primary HRS cells and cHL cell lines. However, a subset of the genes differentially expressed in primary HRS cells, including chemotaxis and surface receptor signaling related genes, were not differentially expressed in the cell lines 26, 28 . This indicates that it is likely that the lncRNA expression profile of the HL cell lines will also not fully reflect the lncRNA profile of primary HRS cells.
Three of the upregulated lncRNAs, i.e. LINC00116, LINC00461 and FLJ42351, were studied in more detail, including expression analysis in primary cHL tissues. RNA-FISH for LINC00116 revealed a remarkable specific expression pattern, with fluorescent signals being restricted to the HRS cells. The qRT-PCR across normal B-cell subsets and lymphoma cell lines showed a similar pattern with a preferential expression in HL cells. TCGA data did not show a preferential expression pattern across multiple other types of cancer. LINC00116 has three known transcript variants, two short variants and one long variant. The longer transcript (LINC00116-001) might encode for a 138 amino acid uncharacterized protein (http://www.uniprot.org/uniprot/Q8NCU8), whereas the shorter variants represent true lncRNA transcripts without protein-coding potential. The expression pattern of the probes present on our array pointed to a predominant expression of the shorter isoforms (LINC00116-002 LINC00116-003, FIG. S3) . Moreover, the probes for RNA-FISH and the primers used for the qPCR were also designed based on these short non-coding transcript isoforms. Thus, our data support a HRS cell specific expression pattern of the two short LINC00116 transcript variants.
LINC00461 also showed a highly specific expression pattern in the HRS cells by RNA-FISH. We also noticed enhanced expression of LINC00461 in HL, DLBCL and LCL cell lines. Analysis of the TCGA data revealed expression only in low-grade gliomas and not in DLBCL tissues. The difference between the qPCR and TCGA results for DLBCL may be related to differences that sometimes can be observed between cell lines and primary tissues. The LINC00461 locus contains several isoforms of which the array probe, the qRT-PCR primer set and the FISH probe-set all detect both the 3.6kb (NR_024384) and the 3.4kb (NR_024383) isoforms (FIG. S3) . The last exon of both lncRNA isoforms contains the pre-miR-9-2 sequence. Whether this lncRNA, besides serving as a primary transcript for miR-9, also has other functions remains to be determined. It has been reported that miR-9 expression is increased in HL and glioma and that inhibition of miR-9 inhibits growth of HL cell lines in a xenograft mouse model [29] [30] [31] [32] . The expression pattern of the nuclear enriched LINC00461 showed an inverse correlation with the expression of the nearby upstream protein-coding gene, MEF2C. MEF2C is essential for B-cell proliferation and survival in response to BCR stimulation in vitro 33 . In vivo, MEF2C loss results in reduced antibody responses to T-cell-dependent antigens and impaired GC formation 33, 34 . Studies in rats have shown that MEF2C can stimulate expression of the miR-9-2 locus by binding to a highly conserved site in the promoter of the miR-9-2 host gene 35 . On the other hand, MEF2C is a predicted miR-9 target via a broadly conserved 8-mer site in the 3'UTR. How LINC00461 and MEF2C regulate each other's expression and to what extend this is relevant for cHL remains to be investigated. FLJ42351, the third lncRNA studied in more detail, also showed a remarkable HRS cell specific expression in primary HL tissues. qPCR confirmed expression in HL cell lines and showed in addition expression in DLBCL and LCL cell lines. TCGA RNA-seq data did not show substantial expression in other types of cancer tissues. The expression pattern of FLJ42351 is similar to that of the immediately downstream phosphate transporter SLC20A1. In line with a cis-regulatory role of FLJ42351 we did observe a preferential nuclear localization in the cHL cell lines. SLC20A1 knockdown in HeLa and hepatic cell lines reduced cell proliferation 36 and SLC20A1 knockout mice showed increased apoptosis rates in erythroid cells 37 . We previously identified FLJ42351 as a MYC-induced transcript in P493-6 cells 17 . In support of a putative cis-regulatory role of this lncRNA, we also identified SLC20A1 as a positively correlating neighboring gene of FLJ42351 in our MYC-regulated lncRNA study. Thus, FLJ42351 is a HRS cell expressed lncRNA whose expression pattern is similar to that of the neighboring protein-coding gene SLC20A1, which is known to have important functions in cell growth.
Despite several attempts we were not able to efficiently knockdown LINC00461 and FLJ42351 with siRNA and lentiviral shRNA based approaches. This precluded a further analysis to provide more definitive proof that these two lncRNAs can indeed regulate the expression of the neighboring genes. Interestingly, both lncRNAs do have a DNase I hypersensitivity site (DHS), which is indicative of regulatory sequences, i.e. ~15 kb upstream of the transcriptional start site (TSS) of LINC00461 in both L1236 and L428 cell lines 38 and ~45 kb downstream of the FLJ42351 TSS in L1236.
In summary, our comprehensive expression analysis shows dynamic regulation of lncRNA expression during the GC transition of B cells and a widely deregulated expression in HL. These lncRNAs, together with the putative cis-acting data, provide a valuable source for further studies aiming at understanding the role of lncRNAs in normal B-cell biology and in the pathogenesis of HL. In bold the lncRNA-mRNA pairs are indicated that overlap with the putative cis-regulated lncRNA-mRNA pairs identified in the transcriptome comparisons of the cHL cell lines with the GC-B cell subsets (Table I ).
